1 min read
Add as a preferred source on GoogleAlignment Healthcare Cut to Neutral as Medicare Rating Falls
BofA Securities lowered its price target to $9 from $25 after CMS reduced a major California Medicare Advantage contract’s rating to 3.5 stars from 4 stars.
BofA Securities downgraded Alignment Healthcare to Neutral from Buy after the Centers for Medicare & Medicaid Services lowered the Star Rating for one of the company’s major California Medicare Advantage contracts.
The contract’s rating fell to 3.5 stars from 4 stars. BofA also reduced its price target for Alignment Healthcare to $9 from $25.
The report was published at 5:59 p.m. ET (21:59 UTC) Friday, Oct. 9.
Enna Lee
ReporterEnna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.